Found 1813 clinical trials
UPENN Case Test Trial 4 (Do Not Make Any Changes)
UPENN Case Test Trial 4 (Do Not Make Any Changes)
- 0 views
- 02 May, 2025
- 1 location
UPENN Case Test Trial 5 (Do Not Make Any Changes)
UPENN Case Test Trial 5 (Do Not Make Any Changes)
- 0 views
- 12 Jun, 2025
UPENN Case Test Trial 12 (Do Not Make Any Changes)
UPENN Case Test Trial 12 (Do Not Make Any Changes)
- 0 views
- 02 May, 2025
UPENN Case Test Trial 13 (Do Not Make Any Changes)
UPENN Case Test Trial 13 (Do Not Make Any Changes)
- 0 views
- 15 May, 2025
Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age
The purpose of this study is to learn about the interactions of markers of type 2 diabetes (T2DM) and periodontitis (PD). Study VPE00001 is a multi-center cross-sectional study. Participants will be categorized based on point-of-care hemoglobin A1c (HbA1c) and periodontal disease (PD) staging into 9 subgroups.
- 0 views
- 14 May, 2025
Incidence of Diabetes and Metabolic Disorders After TIPS in Cirrhotic Patients
Based on our retrospective data, TIPS induces in 30% of cirrhotic patients metabolic disorders associated with diabetes or pre-diabetes. The main objective is to measure the cumulative incidence of diabetes and pre-diabetes 6 months after TIPS insertion.
- 0 views
- 19 Feb, 2024
Internet Intervention for Diabetes Distress.
This study is designed to investigate the potential effectiveness of an internet-delivered intervention for diabetes distress in patients with type 2 diabetes.
- 0 views
- 20 Jun, 2025
- 19 locations
Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects
The objective of this early feasibility study is to evaluate the safety and performance of intravascular hepatic denervation using the Metavention Integrated Radio Frequency Denervation System (iRF System) to improve glycemic control in type 2 diabetes subjects.
- 0 views
- 19 Feb, 2024
Metformin for Abdominal Aortic Aneurysm Growth Inhibition
A multi-centre population-based open-label randomized controlled trial with allocation concealment and blinded outcome assessment will examine if up to 2g metformin daily slows AAA growth in patients with small AAAs who do not have diabetes.
- 0 views
- 19 Feb, 2024
